Pancreatic Cancer Research

ResearcherMoffitt Cancer CenterActive in the last 2 years

Yumi Kim

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-8815-3121; OpenAlex author ID A5100425044. Sources: OpenAlex.

Their work

Papers
4 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2019: 1 paper · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 4

  1. PHGDH is a targetable driver of PDAC progression Co-author DOI 10.64898/2026.03.11.711147↗
  2. Timosaponin A3 Inhibits Palmitate and Stearate through Suppression of SREBP-1 in Pancreatic Cancer. Co-author DOI 10.3390/pharmaceutics14050945↗
  3. Anti-Cancer Potential of Oxialis obtriangulata in Pancreatic Cancer Cell through Regulation of the ERK/Src/STAT3-Mediated Pathway. First author DOI 10.3390/molecules25102301↗
  4. Apoptosis and G2/M cell cycle arrest induced by a timosaponin A3 from Anemarrhena asphodeloides Bunge on AsPC-1 pancreatic cancer cells. Co-author DOI 10.1016/j.phymed.2018.08.006↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hyeung-Jin Jang · 3 shared papers, 2019–2022 · strength 0.42
  2. Gina M. DeNicola · 1 shared paper, 2026 · strength 0.32
  3. H. Carlo Maurer · 1 shared paper, 2026 · strength 0.32
  4. Kenneth P. Olive · 1 shared paper, 2026 · strength 0.32
  5. Eun-Jin An · 2 shared papers, 2020–2022 · strength 0.31
  6. Wona Jee · 1 shared paper, 2022 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.